Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

ATNMATNM
Showing 8 of 23 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in ACTINIUM PHARMACEUTICALS INC

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds 56,822 shares of ATNM (ACTINIUM PHARMACEUTICALS INC), worth $55,685 as of 2026-Q2. The position was decreased (-54.2% shares).

Current Value

$55,685

Current Shares

56,822

Total Value Change

+$13,408

Total Shares Change

+34,334

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
56,822
-54.2%
$55,6850.0%$0.98
0
2026-Q1
Increased
123,998
+50.4%
$123,4150.0%$1.11
21
2025-Q4
Decreased
82,474
-21.8%
$112,1650.0%$1.41
0
2025-Q3
Increased
105,440
+26.9%
$168,7040.0%$1.62
19
2025-Q2
Decreased
83,072
-22.4%
$116,3010.0%$1.42
0
2025-Q1
Increased
106,982
+235.0%
$172,2410.0%$1.81
25
2024-Q4
Increased
31,939
+42.0%
$40,2430.0%$1.17
18
2024-Q3
Decreased
22,488
-44.8%
$42,2770.0%$1.80
0

Other major holders of ATNM: BlackRock Finance, Inc., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used